SCHEMBL887237

SCHEMBL887237

C=CCc1cncnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9606508 0.79 XDH (0.41)
SCHEMBL10651306 0.76
SCHEMBL8040576 0.74
SCHEMBL2050612 0.72
SCHEMBL4805813 0.70 XDH (0.35)
SCHEMBL10618046 0.70 CYP1A2 (0.36)
SCHEMBL9688626 0.70 XDH (0.48)
SCHEMBL20819307 0.70 XDH (0.35)
SCHEMBL11803991 0.70 ALDH1A1 (0.35)
SCHEMBL10822233 0.70 XDH (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5248776-A Multistage reaction with sulfiding, cyclization and oxidative cleavage UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1993-09-28 US claimed
WO-1992010496-A1 ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1992-06-25 WO claimed
JP-1083072-A None JP disclosed
US-20230357767-A1 NOVEL NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF TARGET GENE BONAC CORPORATION (JP) 2023-11-09 US disclosed
EP-4206325-A1 NOVEL NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF TARGET GENE BONAC CORPORATION (JP) 2023-07-05 EP disclosed
US-20230183283-A1 NOVEL GLYCOSIDE COMPOUND AND PRODUCTION METHOD THEREFOR BONAC CORPORATION (JP) 2023-06-15 US disclosed
EP-3527578-A1 NOVEL GLYCOSIDE COMPOUND AND PRODUCTION METHOD THEREFOR Bonac Corporation (JP) 2019-08-21 EP disclosed
US-10377788-B2 Method for producing glycoside compounds BONAC CORPORATION (JP) 2019-08-13 US disclosed
EP-2696681-B1 2'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2018-10-03 EP disclosed
EP-2697242-B1 2'-AZIDO SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2018-10-03 EP disclosed
EP-3301103-A1 METHOD FOR PRODUCING GLYCOSIDE COMPOUNDS BONAC CORPORATION (JP) 2018-04-04 EP disclosed
WO-1998039353-A1 IMPROVED CHIMERIC OLIGONUCLEOTIDE VECTORS THE PERKIN-ELMER CORPORATION (US) 1998-09-11 WO disclosed
US-5750343-A Methods of detecting nucleic acids with nucleotide probes containing 4'-substituted nucleotides and kits therefor SYNTEX INC. (US) 1998-05-12 US disclosed
US-5446137-A Substituent selected from linking group containing modifiers such as biotin, reactive groups, nucleic acids, catalysts, DNA intercalators, minor groove binders, clevage agents, and detectable labels SYNTEX (U.S.A.) INC. (US) 1995-08-29 US disclosed
US-5248776-A Multistage reaction with sulfiding, cyclization and oxidative cleavage UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1993-09-28 US disclosed
WO-1992010496-A1 ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1992-06-25 WO disclosed
JP-S6483072-A PRODUCTION OF 5-ALKYLPYRIMIDINE DERIVATIVE UKI GOSEI KOGYO CO LTD 1989-03-28 JP disclosed
WO-1986000067-A1 PYRIMIDINES THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNI (GB) 1986-01-03 WO disclosed
US-4020073-A Process for O-acylating thallus salts of 2-pyridone TAYLOR EDWARD C 1977-04-26 US disclosed
US-3947488-A O-Acylation using organothallium compounds TAYLOR EDWARD C 1976-03-30 US disclosed